Đang chuẩn bị liên kết để tải về tài liệu:
Treatment adherence and persistence with long-acting somatostatin analog therapy for the treatment of acromegaly: A retrospective analysis

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG

Many patients with acromegaly require medical treatment that includes somatostatin analogs (SSAs). Long-acting SSA formulations are widely used, due in part to increased patient convenience and increased treatment adherence vs daily medications. | Treatment adherence and persistence with long-acting somatostatin analog therapy for the treatment of acromegaly: A retrospective analysis

TÀI LIỆU LIÊN QUAN

Treatment adherence and persistence with long-acting somatostatin analog therapy for the treatment of acromegaly: A retrospective analysis

Study protocol of the RAND-study: A multicenter, prospective cohort study investigating response and adherence to nilotinib treatment in chronic myeloid leukemia

Influence of a patient information program on adherence and persistence with an aromatase inhibitor in breast cancer treatment - the COMPAS study

A community-based nurse-led medication self-management intervention in the improvement of medication adherence in older patients with multimorbidity: Protocol for a randomised controlled trial

Adherence to treatment in children and adolescents with cystic fibrosis: A cross-sectional, multi-method study investigating the influence of beliefs about treatment and parental depressive symptoms

Association between health literacy, general psychological factors, and adherence to medical treatment among Danes aged 50–80 years

The adherence paradox: Guideline deviations contribute to the increased 5-year survival of breast cancer patients

A longitudinal study of non-medical determinants of adherence to R-CHOP therapy for diffuse large B-cell lymphoma: Implication for survival

Development and validation of the General Rehabilitation Adherence Scale (GRAS) in patients attending physical therapy clinics for musculoskeletal disorders

Compliance and persistence with oral bisphosphonates for the treatment of osteoporosis in female patients with rheumatoid arthritis
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.